476 related articles for article (PubMed ID: 14507372)
1. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.
Roemer T; Jiang B; Davison J; Ketela T; Veillette K; Breton A; Tandia F; Linteau A; Sillaots S; Marta C; Martel N; Veronneau S; Lemieux S; Kauffman S; Becker J; Storms R; Boone C; Bussey H
Mol Microbiol; 2003 Oct; 50(1):167-81. PubMed ID: 14507372
[TBL] [Abstract][Full Text] [Related]
2. Essential gene identification and drug target prioritization in Aspergillus fumigatus.
Hu W; Sillaots S; Lemieux S; Davison J; Kauffman S; Breton A; Linteau A; Xin C; Bowman J; Becker J; Jiang B; Roemer T
PLoS Pathog; 2007 Mar; 3(3):e24. PubMed ID: 17352532
[TBL] [Abstract][Full Text] [Related]
3. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans.
De Backer MD; Nelissen B; Logghe M; Viaene J; Loonen I; Vandoninck S; de Hoogt R; Dewaele S; Simons FA; Verhasselt P; Vanhoof G; Contreras R; Luyten WH
Nat Biotechnol; 2001 Mar; 19(3):235-41. PubMed ID: 11231556
[TBL] [Abstract][Full Text] [Related]
4. Integrated antifungal drug discovery in Candida albicans.
Sanglard D
Nat Biotechnol; 2001 Mar; 19(3):212-3. PubMed ID: 11231545
[No Abstract] [Full Text] [Related]
5. Gene Essentiality Analyzed by
Segal ES; Gritsenko V; Levitan A; Yadav B; Dror N; Steenwyk JL; Silberberg Y; Mielich K; Rokas A; Gow NAR; Kunze R; Sharan R; Berman J
mBio; 2018 Oct; 9(5):. PubMed ID: 30377286
[TBL] [Abstract][Full Text] [Related]
6. Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.
Liu M; Healy MD; Dougherty BA; Esposito KM; Maurice TC; Mazzucco CE; Bruccoleri RE; Davison DB; Frosco M; Barrett JF; Wang YK
Eukaryot Cell; 2006 Apr; 5(4):638-49. PubMed ID: 16607011
[TBL] [Abstract][Full Text] [Related]
7. Generation of conditional lethal Candida albicans mutants by inducible deletion of essential genes.
Michel S; Ushinsky S; Klebl B; Leberer E; Thomas D; Whiteway M; Morschhäuser J
Mol Microbiol; 2002 Oct; 46(1):269-80. PubMed ID: 12366849
[TBL] [Abstract][Full Text] [Related]
8. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents.
Tripathi H; Luqman S; Meena A; Khan F
Curr Drug Targets; 2014 Jan; 15(1):136-49. PubMed ID: 24102473
[TBL] [Abstract][Full Text] [Related]
9. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target.
Demuyser L; Palmans I; Vandecruys P; Van Dijck P
mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338
[No Abstract] [Full Text] [Related]
10. Host-Induced Genome Instability Rapidly Generates Phenotypic Variation across Candida albicans Strains and Ploidy States.
Smith AC; Hickman MA
mSphere; 2020 Jun; 5(3):. PubMed ID: 32493724
[No Abstract] [Full Text] [Related]
11. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
Park YN; Morschhäuser J
Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
[TBL] [Abstract][Full Text] [Related]
12. A new rapid and efficient system with dominant selection developed to inactivate and conditionally express genes in Candida albicans.
Lai WC; Sun HF; Lin PH; Ho Lin HL; Shieh JC
Curr Genet; 2016 Feb; 62(1):213-35. PubMed ID: 26497136
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans.
Xu D; Jiang B; Ketela T; Lemieux S; Veillette K; Martel N; Davison J; Sillaots S; Trosok S; Bachewich C; Bussey H; Youngman P; Roemer T
PLoS Pathog; 2007 Jun; 3(6):e92. PubMed ID: 17604452
[TBL] [Abstract][Full Text] [Related]
14. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model.
Becker JM; Kauffman SJ; Hauser M; Huang L; Lin M; Sillaots S; Jiang B; Xu D; Roemer T
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22044-9. PubMed ID: 21135205
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target.
Dobb KS; Kaye SJ; Beckmann N; Thain JL; Stateva L; Birch M; Oliver JD
PLoS One; 2015; 10(11):e0143770. PubMed ID: 26606674
[TBL] [Abstract][Full Text] [Related]
16. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
[TBL] [Abstract][Full Text] [Related]
17. Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.
Li X; Hou Y; Yue L; Liu S; Du J; Sun S
Antimicrob Agents Chemother; 2015 Oct; 59(10):5885-91. PubMed ID: 26195510
[TBL] [Abstract][Full Text] [Related]
18. An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteins.
Bernardo SM; Allen CP; Waller A; Young SM; Oprea T; Sklar LA; Lee SA
PLoS One; 2014; 9(10):e110354. PubMed ID: 25350399
[TBL] [Abstract][Full Text] [Related]
19. A CUG codon-adapted anchor-away toolkit for functional analysis of genes in
Teli BB; Nagar P; Priyadarshini Y; Poonia P; Natarajan K
mSphere; 2024 Feb; 9(2):e0070323. PubMed ID: 38251906
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
